Is reducing variability of blood glucose the real but hidden target of intensive insulin therapy?
-
* Corresponding author: Rinaldo Bellomo rinaldo.bellomo@austin.org.au
Critical Care 2009, 13:302 doi:10.1186/cc7755
Accesses
- Last 30 days: 48 accesses
- Last year: 655 accesses
- All time: 2246 accesses
Cited by
BioMed Central: 3 citations
|
Marcus J Schultz, Robin E Harmsen, Peter E Spronk Critical Care 2010, 14:223 (7 June 2010) |
|
Impact of real-time continuous glucose monitoring on glucose variability in critically ill patients R Brunner, R Kitzberger, W Miehsler, V Fuhrmann, C Madl, U Holzinger Critical Care 2010, 14(Suppl 1):P577 (1 March 2010) |
|
NICE-SUGAR: the end of a sweet dream? Jean-Charles Preiser Critical Care 2009, 13:143 (14 May 2009) |